A researcher at the University of California, San Diego has won a $5.6 million NIH Avant-Garde Award aimed at preventing HIV, hepatitis C and overdose, according to UC San Diego Today.
The Avant-Garde Award is a grant program designed to back bold, high-risk research ideas that could reshape how a problem is tackled. Winning one signals that federal reviewers see unusual promise in the approach, and the multi-million-dollar size of the grant gives the recipient room to pursue work that more conventional funding might not support.
The project ties together three public health threats that frequently overlap. HIV and hepatitis C are both bloodborne infections that can spread through shared needles, and drug overdose has become a leading cause of preventable death. Targeting all three at once reflects how closely they are linked among people who use drugs.
The story is filed under a focus on artificial intelligence, suggesting AI-driven methods are central to the prevention effort, though the source provided here does not spell out the specific tools or techniques involved.
Based on the available source, further details — including the researcher's name, the timeline, and exactly how the technology will be deployed — are not specified beyond the announcement that UC San Diego secured the award.
Why it matters: large federal bets on AI-assisted prevention could point to new ways of curbing infections and overdoses that have long resisted traditional public health tools.